The authors reply [6]

New England Journal of Medicine

Volumn 356, Issue 14, 2007, Pages 1471-1472

  Geyer, Charles E ^a   Forster, John ^b   Cameron, David ^c  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; LAPATINIB; TRASTUZUMAB;

BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG ACTIVITY; DRUG BLOOD LEVEL; HUMAN; LETTER; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 34147096113     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070182     Document Type: Letter

References (1)

1. CE Geyer J Forster D Lindquist Lapatinib plus capecitabine for HER2-positive advanced breast cancer N Engl J Med 355 2006 2733 2743